Table 1 Patient demographic and baseline characteristics
2-DG 63 mg + SOC N = 22 n (%) | SOC1 N = 22 n (%) | 2-DG 90 mg + SOC N = 22 n (%) | 2-DG 126 mg + SOC N = 21 n (%) | SOC2 N = 22 n (%) | ||
|---|---|---|---|---|---|---|
Age (years) | Mean (SD) | 44.2 (12.71) | 44.4 (9.59) | 46.3 (11.00) | 42.7 (9.33) | 46.6 (11.96) |
Weight (kg) | Mean (SD) | 61.3 (9.35) | 67.9 (9.76) | 69.4 (10.52) | 74.2 (12.23) | 70.6 (11.77) |
Gender [n (%)] | Female | 7 (31.8) | 6 (27.3) | 1 (4.5) | 5 (23.8) | 2 (9.1) |
Male | 15 (68.2) | 16 (72.7) | 21 (95.5) | 16 (76.2) | 20 (90.9) | |
Number of days since onset of first symptom of COVID-19 | Mean (SD) | 6.6 (2.26) | 7.2 (2.58) | 4.5 (1.41) | 4.3 (1.46) | 4.4 (1.40) |
Clinical severity status as defined by MoH&FW [n (%)] | Group 1 (Mild) | 0 | 0 | 0 | 0 | 0 |
Group 2 (Moderate) | 21 (95.5%)a | 21 (95.5%)a | 22 (100.0%) | 21 (100.0%) | 21 (95.5%)a | |
Group 3 (Severe) | 0 | 0 | 0 | 0 | 0 | |
Oxygen saturation (SpO2%) | N | 22 | 21 | 22 | 21 | 21 |
Mean (SD) | 93.1 (2.39) | 93.0 (1.82) | 92.7 (1.55) | 92.5 (1.47) | 93.0(2.07) | |
Median | 92.0 | 93.0 | 93.0 | 93.0 | 93.0 | |
Heart rate (beats per minute) | N | 22 | 21 | 22 | 21 | 21 |
Mean (SD) | 85.0 (11.32) | 86.3 (15.17) | 81.3 (10.39) | 84.9 (11.57) | 89.6 (8.48) | |
Median | 80.0 | 84.0 | 80.0 | 88.0 | 89.0 | |
Respiratory rate (per minute) | N | 22 | 21 | 22 | 21 | 21 |
Mean (SD) | 22.1 (3.04) | 21.4 (3.20) | 23.9 (2.41) | 24.4 (2.09) | 24.7 ± 2.61 | |
Median | 24.0 | 22.0 | 25.0 | 25.0 | 25.0 | |
WHO clinical progression scale | N | 22 | 22 | 22 | 21 | 22 |
Mean (SD) | 5.1 (0.35) | 5.0 (0.21) | 4.3 (0.48) | 4.3 (0.46) | 4.3 (0.48) | |
Median | 5.0 | 5.0 | 4.0 | 4.0 | 4.0 |